Position in NVS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$216,141
+$13,610 QoQ
Shares Held
1,415
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PFG Advisors holds $28,669,367 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
28,720 | $7,294,018 | |
| 2 | ABBV |
AbbVie Inc.
|
22,305 | $5,612,830 | |
| 3 | LLY |
ELI LILLY & Co
|
4,488 | $5,383,042 | |
| 4 | AMGN |
Amgen Inc
|
14,633 | $5,298,901 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,306 | $4,022,821 | |
| 6 | PFE |
Pfizer Inc
|
15,983 | $384,870 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,755 | $348,066 | |
| 8 | AZN |
Astrazeneca PLC
|
1,713 | $324,819 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $216,141 | 1,415 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $202,531 | 1,469 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $216,084 | 1,685 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||